Babaamaajimowinan (Telling of news in different places)
Responding to limitations in existing testing methods, health care companies around the world are racing to produce new point-of-care diagnostic systems that can quickly detect the presence of the new coronavirus.
All of the existing devices used to diagnose COVID-19 cases, including Roche's system heralded by President Donald Trump on Friday and a second one from Thermo Fisher Scientific, are laboratory-based systems that require sophisticated analyzers in major hospitals and labs.
Reader Comments(0)